Tech Company Financing Transactions
Proteostasis Therapeutics Funding Round
Private investors participated in a $10 million funding round for Proteostasis Therapeutics. The round was announced on 9/16/2015.
Transaction Overview
Company Name
Announced On
9/16/2015
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing - amended. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
80 Guest St. 5th Floor
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Website
Email Address
Overview
Proteostasis Therapeutics (NASDAQ: PTI) is discovering and developing novel small molecule therapeutics designed to control the body's Proteostasis Network, which maintains the body's natural protein homeostasis to protect us from numerous diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meenu Chhabra
Chief Medical Officer
Po-Shun Lee
Chief Operating Officer
Marija Zecevic
Chief Scientific Officer
Ben Munoz
VP - Bus. Development
Geoffrey Gilmartin
VP - Operations
Sheila Wilson
Browse more venture capital transactions:
Prev: 9/16/2015: Axcella Health venture capital transaction
Next: 9/16/2015: Coalfire Systems venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs